Completed EARLY_PHASE1 INTERVENTIONAL 1-arm NCT03837470

Evaluation of Renal Sodium Excretion After Salt Loading in Heart Failure With Preserved Ejection Fraction (ERES-HFpEF)

Sponsor: Adhish Agarwal

Conditions Heart Failure With Preserved Ejection Fraction

Interventions 0.9% Sodium Chloride Furosemide 40 mg

Updated 8 times since 2019 Last updated: Apr 14, 2021 Started: May 6, 2019 Primary completion: Feb 20, 2020 Completion: Feb 20, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03837470, this EARLY_PHASE1 trial focuses on Heart Failure With Preserved Ejection Fraction and remains completed. Sponsored by Adhish Agarwal, it has been updated 8 times since 2019, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed EARLY_PHASE1
May 2021 — Jul 2024 [monthly]

Completed EARLY_PHASE1

Status: Recruiting → Completed
Jan 2021 — May 2021 [monthly]

Recruiting EARLY_PHASE1
Oct 2020 — Jan 2021 [monthly]

Recruiting EARLY_PHASE1

▶ Show 3 earlier versions

May 2020 — Oct 2020 [monthly]

Recruiting EARLY_PHASE1
Jun 2019 — May 2020 [monthly]

Recruiting EARLY_PHASE1

Status: Not Yet Recruiting → Recruiting
Mar 2019 — Jun 2019 [monthly]

Not Yet Recruiting EARLY_PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Adhish Agarwal
University of Utah Center for Clinical and Translational Science

Data source: University of Utah

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Salt Lake City, United States